288 related articles for article (PubMed ID: 25348370)
21. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
[TBL] [Abstract][Full Text] [Related]
22. Radiation-Associated Chronic Dysphagia Assessment by Flexible Endoscopic Evaluation of Swallowing (FEES) in Head and Neck Cancer Patients: Swallowing-Related Structures and Radiation Dose-Volume Effect.
Ozkaya Akagunduz O; Eyigor S; Kirakli E; Tavlayan E; Erdogan Cetin Z; Kara G; Esassolak M
Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):73-84. PubMed ID: 30343589
[TBL] [Abstract][Full Text] [Related]
23. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
24. Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation.
Tsai CJ; Jackson A; Setton J; Riaz N; McBride S; Leeman J; Kowalski A; Happersett L; Lee NY
JCO Clin Cancer Inform; 2017 Nov; 1():1-7. PubMed ID: 30657398
[TBL] [Abstract][Full Text] [Related]
25. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
[TBL] [Abstract][Full Text] [Related]
26. Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis.
Jiang L; Huang C; Gan Y; Wu T; Tang X; Wang Y; Wang R; Zhang Y
Sci Rep; 2018 Nov; 8(1):16396. PubMed ID: 30401941
[TBL] [Abstract][Full Text] [Related]
27. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
[TBL] [Abstract][Full Text] [Related]
28. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
[TBL] [Abstract][Full Text] [Related]
29. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
[TBL] [Abstract][Full Text] [Related]
30. Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.
Batham S; Gupta S; Ghosh A; Gupta IJ; Johny D; Srivastava S; Singh N; Bhatt M; Gupta R; Bhosale VV; Negi M
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3697-3704. PubMed ID: 38019227
[TBL] [Abstract][Full Text] [Related]
31. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
[TBL] [Abstract][Full Text] [Related]
32. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT).
Peponi E; Glanzmann C; Willi B; Huber G; Studer G
Radiat Oncol; 2011 Jan; 6():1. PubMed ID: 21208415
[TBL] [Abstract][Full Text] [Related]
33. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
Joint Head and Neck Radiotherapy-MRI Development Cooperative
Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
[TBL] [Abstract][Full Text] [Related]
34. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
[TBL] [Abstract][Full Text] [Related]
35. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
36. The Changes in Pharyngeal Constrictor Muscles Related to Head and Neck Radiotherapy: A Systematic Review.
Grepl J; Sirak I; Vosmik M; Tichy A
Technol Cancer Res Treat; 2020; 19():1533033820945805. PubMed ID: 32734851
[TBL] [Abstract][Full Text] [Related]
37. A predictive model for dysphagia following IMRT for head and neck cancer: introduction of the EMLasso technique.
De Ruyck K; Duprez F; Werbrouck J; Sabbe N; Sofie de L; Boterberg T; Madani I; Thas O; Wilfried de N; Thierens H
Radiother Oncol; 2013 Jun; 107(3):295-9. PubMed ID: 23618501
[TBL] [Abstract][Full Text] [Related]
38. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
39. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.
Werbrouck J; De Ruyck K; Duprez F; Veldeman L; Claes K; Van Eijkeren M; Boterberg T; Willems P; Vral A; De Neve W; Thierens H
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1187-95. PubMed ID: 19251090
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
Bhide SA; Gulliford S; Fowler J; Rosenfelder N; Newbold K; Harrington KJ; Nutting CM
Radiother Oncol; 2010 Oct; 97(1):86-91. PubMed ID: 20826031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
